Abata Therapeutics
ClosedWatertown, United States · Founded 2021
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- abata.com
- Last Round
- Series AJun 2021
- Rounds
- 1
Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.
About
Abata Therapeutics was a clinical-stage biotech company dedicated to developing engineered regulatory T cell (Treg) therapies for severe autoimmune and inflammatory diseases, with lead programs in progressive multiple sclerosis and type 1 diabetes. Founded in 2021 by Third Rock Ventures, the company shut down in 2025 after being unable to secure additional funding.
Summary
Abata Therapeutics is a Biotech company based in Watertown, United States, founded in 2021. Its most recent funding was a Series A round in Jun 2021. Investors include Third Rock Ventures, Lightspeed Venture Partners and Invus.
Tech & App Stack
8 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2021
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/abata-therapeutics"><img src="https://indexed.vc/api/badge/company/abata-therapeutics" alt="Abata Therapeutics on Indexed.vc" width="260" height="76" /></a>